Medication info
Acvi Tablets (Acyclovir)

Acvi Tablets (Acyclovir)

Prescription medicationTabletIntravenous injection
Ingredient · strength
Acyclovir›200mg / 1 tablet
Manufacturer / importer
NBK Pharmaceutical Co., Ltd.
Appearance
Light blue round tablets
Packaging
Bottle - 30 tablets/bottle, Bottle - 200 tablets/bottle
Approval status
Active

MFDS item code 202003387 · Approved 2020.05.11 · Insurance code 054801060

Summary

Main use
Treatment and prevention of herpes simplex, treatment of herpes zoster, and treatment of chickenpox in children
Who receives it
Adults · Children
Adult administration
○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. 2) In patients with severe immunocompromise (such as after bone marrow transplantation) or gastrointestinal absorption disorders, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) Treatment should be started as soon as possible after infection. For recurrent infections, it is preferable to start treatment at the first appearance of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this drug 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be periodically interrupted every 6 ~ 12 months. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this drug 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (such as after bone marrow transplantation) or gastrointestinal absorption disorders, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this drug 5 times daily at approximately 4-hour intervals, except during sleep, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunocompromise or gastrointestinal absorption disorders. 3) Treatment should be started as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Since patients with renal impairment are more likely to experience neuropsychiatric adverse reactions, use caution, for example by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would result in accumulation following intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL/min), it is preferable to administer 200 mg of this drug every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL/min, it is preferable to reduce the dose to 800 mg of this drug twice daily at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL/min, it is preferable to reduce the dose to 800 mg of this drug 3 times daily at approximately 8-hour intervals.
Child administration
○ Pediatric patients 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) 2 years and older: Same as adults. 2) Under 2 years: Administer 1/2 the adult dose. 3) There are currently no reliable data on prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children 2 years and older: Administer 20 mg/kg of this drug per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.

Ingredients

Manufacturer
NBK Pharmaceutical Co., Ltd.

Efficacy & effects

Treatment and prevention of herpes simplex, treatment of herpes zoster, and treatment of chickenpox in children

  • Genital herpes
  • herpes simplex virus infections of the skin and mucous membranes
  • shingles virus infection
  • acute phase pain
  • chickenpox.
View approved original text

This medication is used to treat and prevent infections caused by the herpes simplex virus, including primary and recurrent genital herpes. It also treats shingles virus infections and is particularly effective for pain relief during acute phases. However, its effectiveness for postherpetic neuralgia has not yet been clearly proven. Additionally, it can be used to treat chickenpox in children over 2 years of age. This is a medication that is broadly helpful for treating various viral infections.

How it is given

Adult administration

○ Adults 1. Treatment of herpes simplex virus infections 1) Administer acyclovir 200 mg per dose 5 times daily at 4-hour intervals for 5 days. Treatment may be extended for severe initial infections. 2) In patients with severe immunocompromise (such as after bone marrow transplantation) or gastrointestinal absorption disorders, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) Treatment should be started as soon as possible after infection. For recurrent infections, it is preferable to start treatment at the first appearance of prodromal symptoms or lesions. 2. Prevention of herpes simplex infections in patients with normal immune function 1) Administer 200 mg of this drug 4 times daily at approximately 6-hour intervals. Alternatively, 400 mg may be administered twice daily at 12-hour intervals. 2) The dose may then be reduced to 200 mg 2 ~ 3 times daily after confirming its efficacy. 3) To assess the natural course of the disease, long-term treatment should be periodically interrupted every 6 ~ 12 months. 3. Prevention of herpes simplex infections in immunocompromised patients 1) Administer 200 mg of this drug 4 times daily at approximately 6-hour intervals. 2) In patients with severe immunocompromise (such as after bone marrow transplantation) or gastrointestinal absorption disorders, the dose per administration may be increased to 400 mg or the route of administration may be changed to intravenous injection. 3) Administer during the period of risk of infection. 4. Treatment of herpes zoster infections 1) Administer 800 mg of this drug 5 times daily at approximately 4-hour intervals, except during sleep, for a total of 7 days. 2) Intravenous administration should be considered in patients with severe immunocompromise or gastrointestinal absorption disorders. 3) Treatment should be started as soon as possible after infection; the earlier treatment is started, the better the effect. ○ Patients with renal impairment Since patients with renal impairment are more likely to experience neuropsychiatric adverse reactions, use caution, for example by extending the dosing interval or reducing the dose. 1. Treatment of herpes simplex infections The oral dose is generally not higher than the amount that would result in accumulation following intravenous administration. However, in patients with severe renal impairment (creatinine clearance less than 10 mL/min), it is preferable to administer 200 mg of this drug every 12 hours. 2. Treatment of herpes zoster virus infections 1) In patients with creatinine clearance less than 10 mL/min, it is preferable to reduce the dose to 800 mg of this drug twice daily at approximately 12-hour intervals. 2) In patients with creatinine clearance of 10 ~ 25 mL/min, it is preferable to reduce the dose to 800 mg of this drug 3 times daily at approximately 8-hour intervals.

Child administration

○ Pediatric patients 1. Treatment of herpes simplex infections and prevention of herpes simplex infections in immunocompromised patients 1) 2 years and older: Same as adults. 2) Under 2 years: Administer 1/2 the adult dose. 3) There are currently no reliable data on prevention of herpes simplex virus infections in patients with normal immune function. 2. Treatment of chickenpox in children 2 years and older: Administer 20 mg/kg of this drug per dose (maximum 800 mg per dose) 4 times daily for 5 days. Treatment should be started as soon as possible after the chickenpox rash appears, preferably within 24 hours of rash onset.

Precautions

This medication should not be used in patients with known allergies to this drug or its components. Patients with impaired kidney function are at risk of experiencing neurological reactions while using this drug, so caution is necessary. Patients with impaired liver function should also use this drug cautiously as liver function may worsen with its use. Extra caution is advised when administering this drug to infants and young children, using the minimum effective dose when necessary. Elderly patients often have decreased kidney function, which may increase the concentration of this drug, so dosage and administration intervals should be adjusted accordingly. Rarely, this drug may cause serious allergic reactions such as anaphylactic shock; if symptoms such as low blood pressure, breathing difficulties, or chest tightness occur, administration should be stopped immediately and appropriate treatment should be sought. Skin reactions such as photosensitivity, rashes, fever, vesicles, or hives may develop, and if these occur, the medication should be discontinued, and a doctor consulted. Rarely, severe skin disorders such as Stevens-Johnson syndrome or toxic epidermal necrolysis may occur, so skin condition should be carefully monitored. Neurological symptoms may include altered consciousness, confusion, hallucinations, seizures, drowsiness, and anxiety, particularly in elderly patients or those with kidney impairment. Signs of impaired kidney function may include renal failure, hematuria, or proteinuria; kidney function should be regularly monitored. Blood abnormalities such as leukopenia, anemia, or bleeding may occur, so blood tests to assess the situation are important. Signs of liver dysfunction may include hepatitis, jaundice, or increased liver function test results; liver health should be closely monitored. Gastrointestinal symptoms may include gastritis, nausea, vomiting, diarrhea, or abdominal pain; if these symptoms are severe, the medication should be discontinued and a doctor consulted. Adequate hydration is necessary during treatment with this drug; particularly with high doses, it is important to drink plenty of water to prevent dehydration and to reduce the risk of kidney toxicity. This medication should be administered as soon as possible after the onset of symptoms, ideally within 5 days of herpes zoster or chickenpox symptom onset. For the treatment of recurrent genital herpes, consult a doctor on whether to continue use for more than a year. Consciousness-related disturbances may occur during treatment; caution is advised against operating vehicles or hazardous machinery. This medication may interact with other drugs, so it is important to inform your doctor, especially if using drugs that affect kidney function or certain other medications. Pregnant women or women who may become pregnant should carefully consider the risks and benefits of using this medication, and it is advisable to discontinue breastfeeding while taking it. In the event of an overdose, symptoms of kidney damage or central nervous system abnormalities may occur, so immediate medical assistance should be sought, and blood dialysis may be required if necessary.

Side effects

  • Anaphylactic shock
  • anaphylaxis-like reaction
  • hypotension
  • dyspnea
  • chest tightness
  • photosensitivity reaction
  • fixed drug eruption
  • rash
  • fever
  • vesicles
Show 117 more
  • urticarial erythema
  • hives
  • alopecia
  • erythema multiforme
  • Stevens-Johnson syndrome
  • toxic epidermal necrolysis
  • altered consciousness
  • disorientation
  • concentration disorder
  • aggressive behavior
  • depersonalization
  • anxiety
  • ataxia
  • coma
  • confusion
  • delirium
  • stuttering
  • encephalopathy
  • hallucination
  • psychosis
  • convulsions
  • drowsiness
  • tremors
  • agitation
  • amnesia
  • insomnia
  • anxiety
  • soliloquy
  • dysesthesia
  • ataxia
  • inability to walk
  • involuntary movements
  • nystagmus
  • renal failure
  • crystalluria
  • elevated BUN
  • elevated serum creatinine
  • hematuria
  • proteinuria
  • urinary red blood cell casts
  • purulent urine
  • leukoclast vasculitis
  • lymphadenopathy
  • bleeding
  • purpura
  • anemia
  • leukopenia
  • leukocytosis
  • eosinophilia
  • lymphocytosis
  • thrombocytosis
  • granulocytopenia
  • thrombocytopenia
  • basophilia
  • hepatitis
  • liver dysfunction
  • jaundice
  • abnormal liver function tests
  • hepatomegaly
  • gastritis
  • thirst
  • constipation
  • acute pancreatitis
  • diarrhea
  • loose stools
  • epigastric pain
  • gastric pain
  • abdominal pain
  • nausea
  • vomiting
  • dyspepsia
  • loss of appetite
  • glossitis
  • fever
  • peripheral edema
  • syncope
  • pallor
  • muscle weakness
  • fatigue
  • generalized malaise
  • headache
  • arthralgia
  • myalgia
  • arrhythmia
  • chest pain
  • hypertension
  • hypotension
  • tachycardia
  • palpitations
  • urinary obstruction
  • dysuria
  • glycosuria
  • pneumonia
  • pharyngitis
  • pleural effusion
  • pain
  • hearing loss
  • conjunctivitis
  • visual disturbances
  • taste disorders
  • alopecia
  • sweating
  • hyponatremia
  • low serum protein
  • elevated total cholesterol levels
  • elevated triglyceride levels
  • elevated serum potassium levels
  • decreased serum albumin levels
  • anxiety
  • coma
  • convulsions
  • drowsiness
  • confusion
  • hallucination
  • agitation
  • epileptic seizures
  • state of coma

Not everyone experiences these, and they can vary from person to person.

Storage

This medication may be sensitive to air and humidity, so it must be stored in a tightly sealed container. It is best stored at room temperature between 1 to 30 degrees Celsius. This will help maintain the efficacy of the drug for a longer period.

Appearance and packaging

Appearance

Light blue round tablets

Package unit

Bottle - 30 tablets/bottle, Bottle - 200 tablets/bottle

Same-ingredient medicines

Even with the same ingredient, strength, dosage form and how it is taken can differ.

Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.

Questions about this medicine

No questions yet.

For anything that needs medical judgment, consult a doctor or pharmacist.

Related searches

Search tags

Suggested searches

This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.